Cargando…
Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017)
Following the submission of application EFSA‐GMO‐RX‐017 under Regulation (EC) No 1829/2003 from Bayer Agriculture BVBA the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renew...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844672/ https://www.ncbi.nlm.nih.gov/pubmed/33537065 http://dx.doi.org/10.2903/j.efsa.2021.6375 |
_version_ | 1783644397691207680 |
---|---|
author | Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Álvarez, Fernando Ardizzone, Michele Raffaello, Tommaso |
author_facet | Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Álvarez, Fernando Ardizzone, Michele Raffaello, Tommaso |
collection | PubMed |
description | Following the submission of application EFSA‐GMO‐RX‐017 under Regulation (EC) No 1829/2003 from Bayer Agriculture BVBA the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the insect‐resistant and herbicide‐tolerant genetically modified maize MON 88017 × MON 810, for food and feed uses, excluding cultivation within the European Union. The data received in the context of this renewal application contained post‐market environmental monitoring reports, a systematic search and evaluation of literature, and updated bioinformatic analysis. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequences of the events in maize MON 88017 × MON 810 considered for renewal are identical to the sequence of the originally assessed events, the GMO Panel concludes that there is no evidence in renewal application EFSA‐GMO‐RX‐017 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize MON 88017 × MON 810. |
format | Online Article Text |
id | pubmed-7844672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78446722021-02-02 Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017) Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Álvarez, Fernando Ardizzone, Michele Raffaello, Tommaso EFSA J Scientific Opinion Following the submission of application EFSA‐GMO‐RX‐017 under Regulation (EC) No 1829/2003 from Bayer Agriculture BVBA the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the insect‐resistant and herbicide‐tolerant genetically modified maize MON 88017 × MON 810, for food and feed uses, excluding cultivation within the European Union. The data received in the context of this renewal application contained post‐market environmental monitoring reports, a systematic search and evaluation of literature, and updated bioinformatic analysis. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequences of the events in maize MON 88017 × MON 810 considered for renewal are identical to the sequence of the originally assessed events, the GMO Panel concludes that there is no evidence in renewal application EFSA‐GMO‐RX‐017 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize MON 88017 × MON 810. John Wiley and Sons Inc. 2021-01-29 /pmc/articles/PMC7844672/ /pubmed/33537065 http://dx.doi.org/10.2903/j.efsa.2021.6375 Text en © 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Scientific Opinion Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Álvarez, Fernando Ardizzone, Michele Raffaello, Tommaso Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017) |
title | Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017) |
title_full | Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017) |
title_fullStr | Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017) |
title_full_unstemmed | Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017) |
title_short | Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017) |
title_sort | assessment of genetically modified maize mon 88017 × mon 810 for renewal authorisation under regulation (ec) no 1829/2003 (application efsa‐gmo‐rx‐017) |
topic | Scientific Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844672/ https://www.ncbi.nlm.nih.gov/pubmed/33537065 http://dx.doi.org/10.2903/j.efsa.2021.6375 |
work_keys_str_mv | AT assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT naegelihanspeter assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT bressonjeanlouis assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT dalmaytamas assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT dewhurstiancrawford assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT epsteinmichellem assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT firbanklesliegeorge assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT guerchephilippe assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT hejatkojan assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT morenofranciscojavier assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT mullinsewen assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT noguefabien assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT rostoksnils assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT sanchezserranojosejuan assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT savoinigiovanni assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT veromanneve assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT veronesifabio assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT alvarezfernando assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT ardizzonemichele assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 AT raffaellotommaso assessmentofgeneticallymodifiedmaizemon88017mon810forrenewalauthorisationunderregulationecno18292003applicationefsagmorx017 |